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PERSPECTIVE
Why a Macroeconomic Perspective
Is Critical to the Prevention of
Noncommunicable Disease
Richard Smith
Effective prevention of noncommunicable diseases will require changes in how we live, and
thereby effect important economic changes across populations, sectors, and countries. What we
do not know is which populations, sectors, or countries will be positively or negatively affected
by such changes, nor by how much. Without this information we cannot know which policies
will produce effects that are beneficial both for economies and for health.
Bill Shankly (manager of Liverpool FootballClub from 1959 to 1974) said football (soc-cer) is “not just a matter of life and death,
it’s more important than that.” For economists, so
are noncommunicable diseases (NCDs) (1). Not
only are the effects of NCDs felt throughout the
economy (Table 1), but since the agents contributing
to NCDs are influenced by our lifestyles, effective
preventive policies are likely to includemechanisms
that themselves have appreciable economic impacts,
such as taxing soft-drinks, increasing the use of
public transport, or promoting lower-polluting ener-
gy sources (2, 3). Although the impacts of such
policies may improve health, there will be substan-
tive economic impacts as they ripple out through
the economy, generating differential effects across
various sectors, such as housing, transport, and ag-
riculture. These economic effects may generate yet
further health effects, which themselves then feed
into the economy, generating yet more cycles of
effects. This interaction and reciprocity between
NCDs and the economy highlights the critical need
for a macroeconomic perspective in the design,
implementation, and evaluation of preventive pol-
icies to tackle NCDs.
Macroeconomics, as compared with microeco-
nomics (which is focused upon “partial equilibrium”
within a single sector, such as for housing or meat),
is concerned with general equilibrium across all
sectors, and thus how changes in one sector (e.g.,
increase in price) affect other sectors, with all these
changes together comprising the overall “economic
impact” of a single change (4, 5). For instance, the
impact of pandemic influenza on the healthcare
sector is minimal compared with its effect on gross
domestic product (GDP) through impacts on other
sectors (e.g., hotels, leisure, travel), which are a
consequence of changes in individual behavior in
response to pandemic threat and the mitigation
policies themselves (6, 7).
Why Is This Important for NCD Prevention?
NCDs, such as diabetes, cancer, and heart disease,
differ from infectious diseases, such as pandemic
influenza, as they are not transmitted from person to
person [although there is evidence emerging in the
social sciences of “social contagion,” where social
networks appear to influence the probability of obe-
sity, for instance (8)]. However, they also differ in
that they are intrinsically lifestyle diseases, and hence
the cause and impact are linked in a multiplicity
of ways to everyday economic activity (Fig. 1).
NCD-related health (Fig. 1, box 1) is deter-
mined directly by risk factors (Fig. 1, box 2),
which include genetic predisposition to disease,
such as diabetes and heart disease, but also by a
range of other social determinants of health, which
refer to the general conditions in which people live
and work, including levels and types of employ-
ment, environmental conditions, and education (9).
These social determinants, contribute to the risk of
different diseases, such as pollution-related diseases
and cancer. They are also intimately linkedwith the
household and individual (Fig. 1, box 3), which
represent how people behave and, crucially, invest
(or disinvest) in their health by what they consume
and in the activities they undertake (8). For exam-
ple, cancer and heart disease riskwill be affected by
decisions concerning smoking, alcohol consump-
tion, and exercise. But riskwill also influence house-
hold and individual behavior. For instance, an
individual’s knowing that they have a higher ge-
netic risk of heart disease may modify individual
consumption of fast food. The healthcare sector
(Fig. 1, box 4) comprises goods and services con-
sumed by households principally to improve health
status. Although these affect NCD-related health
directly, they also impact on the household economy,
which ultimately pays for them through taxation,
insurance, or out-of-pocket. The level of ill-health
caused by NCDs will also feed back and impact on
the household, thus further affecting the risk of other
health problems through reducing household in-
come, and feed into healthcare provision through
shaping the demand for services, and hence profile
of provision (e.g., more insulin prescriptions).
Activity in all non-healthcare sectors in the eco-
nomy (Fig. 1, box 5), such as agriculture, manufac-
turing, and education, impacts on the previous three
components and, thus, NCDs. It is well established,
for instance, that “wealthier is healthier” (10, 11), but
that wealth also brings an increase in NCD risk,
such as through changes in dietary habits, with the
suggestion that in some cases this means that eco-
nomic recessions can have positive health benefits
(12). As countries grow wealthier, their populations
experience increased desirability and availability of
processed foods, perhaps mostly starkly indicated
by the experience of somePacific island populations
where traditional diets have been displaced with
high-fat imported foodstuffs and a concomitant in-
crease in obesity rates and NCDs. Similarly, the
transformation of food retail as countries become
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more integrated in the global trading system has
facilitated a pronounced shift to the consumption of
processed food, and multinational fast-food outlets
have made substantial investments in growing eco-
nomies (13). It is also accepted that health positively
affects the general economy through a fitter, more
educated, and more productive workforce (14). In-
security, as labor moves from one sector or location
to another, generates ill-health directly through the
stress caused by economic and social dislocation,
and indirectly by increasing poverty (15). Econom-
ic well-being, tax rates, and other aspects also affect
healthcare spending.
Finally, influences beyond our political borders
act on these components (Fig. 1, box 6). For in-
stance, climate change is a global issue with local
consequences for NCD risk factors. Problems with
subprime lending in the United States, or the Euro
crisis, will affect household employment, income,
and inflation in the United Kingdom, too. The
migration of health professionals affects the ability
to provide services required to treat NCDs.
Prices Are Pivotal
For economics, prices are pivotal. They enable ex-
change of goods and services and, crucially, deter-
mine the point of equilibrium, where demand and
supply are balanced. Any change within the eco-
nomy will affect price directly or indirectly, which
will then disrupt this balance, and each sector will
then have to adjust to a new equilibrium through
changes in other prices. It is a simple, largely au-
tomatic, system that has profound implications for
NCD prevention—illustrated by the current enthu-
siasm for a “fat tax” as a mechanism for reducing
consumption of foods high in saturated fat through
increasing their price. Such a tax has been im-
plemented in Denmark and Hungary and is now
being considered by many others (16, 17).
The argument is simple. The current price
of foods high in saturated fat does not adequate-
ly reflect the negative health effects, leading to
overconsumption (compared to a hypothecated
equilibrium where such health effects were cap-
tured in the price). Government can apply a tax
to address this “market failure,”which increases
price. We know that, in general, increasing price
leads to a reduction in demand, which reduces
consumption, and thus should reduce rates of
NCD. Microeconomic, partial-equilibrium anal-
ysis will tell us how sensitive this demand is to a
change in price (which we know is actually not
very sensitive in the case of most foods) and thus
by how much price needs to increase (usually,
therefore, a lot) (16). The problem, from amacro-
economic perspective, is that it does not tell us
anything at all about how other sectors will adjust
and thus we cannot know what the overall net
impact on the wider economy, or even health,
will actually be.
Consider an example where such a tax in-
creases the price of beef. How might consumers
react? Any change in price will cause a recal-
ibration of expenditure across the range of goods
and services that individuals consume, not just
beef. At the extremes, consumers may either
reduce spending on beef, to keep spending on
everything else the same, or spend less on some-
thing else to keep beef consumption the same.
What are the implications of these two scenarios?
If consumers reduce their demand for beef,
then beef farmers will experience reduced in-
come. Remember that the price is higher as a
result of a tax, and hence this extra revenue per
unit of beef goes not to the farmer, but to the
government—generating further questions about
what this tax revenue would be spent on, such as
subsidizing fruit and vegetables versus reducing
income tax, and the implications of that, which
we don’t have time to consider here. As beef
is less attractive to produce, farmers will trans-
fer production to other products. Which other
products is then the critical question. If it is
biofuels, for example, this may have positive
effects on the environment and thus further de-
crease risk factors for NCDs and multiply the
health effect. Alternatively, if farmers switch to
producing lamb, the increased supply will mean
that the price of lambwill fall, and it may largely
replace beef in the national diet, negating health
benefits from reduced beef consumption.
Farmers could instead focus on increasing ex-
ports of beef, thus increasing consumption, and
rates of NCDs, in other countries and effectively
“exporting” the health problem. What if the beef
consumed in one country is imported from an-
other? In this case, it is possible that a taxmay not
be able to be levied, as it may violate World
Trade Organization requirements if the country is
a member state. But if a “fat tax” could be levied,
then there are economic advantages as less in-
come would be transferred overseas as beef
imports declined (which will affect balance of
payments and currency valuationwith further spill-
over effects). However, again there could be neg-
ative health and economic implications for the
countries from which the beef was imported. For
example, although changing to a healthy diet may
be beneficial for the United Kingdom, if this is
achieved through reduced imports of beef, then
Brazil (as the world’s largest exporter of beef) may
see a substantive negative impact on its economy,
and consequently its population’s health (18).
But what if consumers keep consuming beef,
and instead spend less on something else? If less
is spent on fruit and vegetables, for example, then
this could make health worse. Alternatively, con-
sumers may spend less on car travel, which could
have further positive health benefits from re-
duced emissions, or spend less on leisure activ-
ities, possibly having negative health implications
from reduced exercise, and certainly having eco-
nomic implications for those sectors. Or they may
spend less on flat-screen televisions or computer
games, perhaps generating positive health effects
if this leads to increased active leisure pursuits.
As above, this spending reduction may affect im-
ported goods, generating effects on the balance of
payments of other countries and exchange rates.
The ripples continue.
Thus, we know that such a food tax would
impact directly on consumption patterns, but af-
ter that we know little about what will happen. A
food tax will affect the risk of NCDs in an unpre-
dictable manner as it begins to indirectly influ-
Rest of the world
The economy
Household/IndividualNCD risk factors Healthcare
NCD-related health
2 3 4
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Fig. 1. Noncommunicable diseases and the macroeconomy.
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ence other sectors in the national economy and
interface with the rest of the world. If the net ef-
fect is to increase health, then this should feed
positively into the economy itself, by reducing
healthcare costs and by improving workforce pro-
ductivity. However, we do not know that this will
be the effect, because we do not consider the
broader macroeconomic picture.
What Is the Solution?
We know that a more comprehensive and in-
tegrated economic approach is required for devel-
oping optimal strategies for preventing and coping
with NCDs; the health sector alone cannot achieve
the required reduction in NCDs. We also know
that there will be differential effects from these
strategies across populations, sectors, and coun-
tries.What we do not know is which populations,
sectors, or countries will be positively or nega-
tively affected, or by how much.
As indicated above, to generate the most ef-
fective and acceptable policies to improve NCD
prevention there is need to engage with macro-
economic factors to generate optimal prices, sub-
sidies, safety nets, trade agreements, and so forth
if a country decides it is advantageous to nudge its
population toward healthier behavior. This presents
several challenges, such as the specification of
causal pathways and mechanisms to reconcile
and balance non-health (e.g., employment) ver-
sus health outcomes. Thus, to make the unknowns
known will require a substantial paradigm shift
in academic, professional, and policy circles (19).
Critically, studies concerning the whole-economy
effects at a global level are required. Current evi-
dence tends to focus either upon the broad, gen-
eral, effect of changes in disease upon the economy,
or of changes in the economy upon disease (12),
or focus upon a specific sector (e.g., studies con-
cerning “fat taxes” tend to consider the impact of
a price increase only on the food of interest) (16).
Very few studies consider the cross-sectoral or
cross-country causes or impacts of NCDs, and
measures that may be used to prevent NCDs, or
integrate the economic and health effects (18).
Yet without this information, we cannot know
which policies will produce net beneficial effects,
for the economy or health, or what countervailing
polices may be required to minimize negative
spillovers.
Because NCDs affect the economy so pro-
foundly and pervasively, we also need to quantify
these effects, as it is often the economic case that
swings the agenda and mobilizes resources. The
history of communicable disease, in this respect,
provides valuable lessons. The economic impact
of HIV/AIDS, tuberculosis, and malaria in
particular was important in mobilizing initiatives
such as the President’s Emergency Plan for AIDS
Relief and The Global Fund to Fight AIDS, Tu-
berculosis and Malaria. This was due in part to
the WHO Commission on Macroeconomics and
Health in 2000, which established firmly that in-
vestments to reduce such diseases would be a pri-
mary driver ofmacroeconomic development (14).
HavingHIV/AIDS as the first health-focusedUN
high-level meeting in 2001was also prompted by
the devastating effect the virus was having on
African economies (14). The second health-
focused UN high-level meeting on the NCD chal-
lenge, in 2011, also stressed the economic impact
of chronic disease (1). With the resolution of the
65th World Health Assembly in 2012 to reduce
premature deaths from NCDs by 25% by 2025,
the imperative now is to formulate strategies to
achieve this target, which requires us to recognize
that NCD prevention is “not just a matter of life
and death, it’s more important than that.”
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Table 1. Projected foregone national income due to heart disease, stroke, and diabetes, 2006 to
2015 (20).
Foregone GDP (U.S. $ billions) Cumulative GDP loss(U.S. $ billions) by 2015
2006 2015 2015
(as a percentage
of 2006 estimates)
China 1.01 1.84 182 13.81
India 1.35 1.96 145 16.68
Russia 1.49 1.64 110 16.09
Brazil 0.33 0.50 150 4.18
Indonesia 0.33 0.53 158 4.18
Mexico 0.48 0.89 186 7.14
Turkey 0.39 0.52 133 4.70
Pakistan 0.15 0.21 140 1.72
Thailand 0.12 0.18 150 1.49
Bangladesh 0.08 0.14 175 1.14
Ukraine 0.13 0.13 100 1.33
Egypt 0.11 0.14 125 1.26
Argentina 0.13 0.16 125 1.40
Burma 0.03 0.06 200 0.43
Iran 0.08 0.13 167 0.99
Poland 0.17 0.23 133 2.17
South Africa 0.16 0.21 133 1.88
Philipines 0.06 0.07 133 0.62
Colombia 0.07 0.10 150 0.82
Vietnam 0.02 0.03 200 0.27
Nigeria 0.12 0.12 100 1.17
Ethiopia 0.03 0.03 100 0.16
DR Congo 0.00 0.03 140 0.15
Total 6.8 9.8 83.8
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